Ramsay Health Care unveils plan to separate Ramsay Santé in strategic shift

The Ramsay Health Care (ASX: RHS) share price is in focus today after the company announced plans to separate its European subsidiary, Ramsay Santé, through an in-specie distribution to shareholders.

What did Ramsay Health Care report?

• Completed a strategic review of its 52.79% shareholding in Ramsay Santé
• Proposes to distribute Ramsay Santé shares to Ramsay shareholders via a scheme of arrangement
• Plan to allow shareholders to hold Ramsay Santé shares through CHESS Depositary Interests (CDIs) tradeable on the ASX
• Expected implementation of demerger by December 2026, subject to approvals
• Termination of shareholder agreement with Prédica, effective October 2026

What else do investors need to know?

Ramsay Santé operates independently with its own management, board, and balance sheet. The separation aims to streamline Ramsay’s operations, allowing management to focus on its core Australian hospital business while letting Ramsay Santé pursue its European growth strategy.

Ramsay shareholders will receive proportional shares in Ramsay Santé. The company plans to facilitate ASX trading through CDIs, which are designed to provide the same economic benefit as ordinary Ramsay Santé shares. The distribution remains subject to shareholder, regulatory, and court approvals.

The company estimates a timeline that includes the release of FY26 results in February, key demerger documents in October, a shareholder vote in November, and completion by December 2026. Shareholder agreement with major French partner Prédica will terminate in October 2026 as part of these changes.

What did Ramsay Health Care management say?

Managing Director and Group CEO Natalie Davis said:

Our proposal recognises the different strategies and capital needs of Ramsay and Ramsay Santé, and aims to unlock value for our shareholders while creating opportunities for focused growth in each business.

What’s next for Ramsay Health Care?

If all approvals are secured, Ramsay expects to complete the in-specie distribution late in 2026. Management says simplifying the company’s structure will allow Ramsay to concentrate resources on transforming and growing its Australian hospital operations. Meanwhile, Ramsay Santé will continue as an independently managed, Europe-focused health provider.

The board remains open to alternative outcomes that may better serve shareholder interests. Investors will be kept updated, with no immediate action required at this stage.

Ramsay Health Care share price snapshot

Over the past 12 months, Ramsay Healthcare shares have risen 9%, trading in line with the S&P/ASX 200 Index (ASX: XJO).

View Original Announcement

The post Ramsay Health Care unveils plan to separate Ramsay Santé in strategic shift appeared first on The Motley Fool Australia.

More reading

• Qube reports record half-year result and higher dividend
• Guzman y Gomez posts 1H26 earnings
• DigiCo Infrastructure REIT posts 1H FY26 earnings and accelerates SYD1 expansion
• QBE Insurance posts 2025 profit and dividend increase in FY25
• 5 things to watch on the ASX 200 on Friday

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.